“Skin manifestations associated with Glucagon-Like Peptide-1 (GLP-1) receptor agonist use for weight loss: A cross-sectional analysis”, J Pak Assoc Dermatol, vol. 36, no. 1, pp. 3–9, Mar. 2026, doi: 10.66344/jpad.v36i1.3221.